UBS AM’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Buy
31,561
+4,612
+17% +$339K ﹤0.01% 1953
2025
Q4
$1.83M Buy
26,949
+6,451
+31% +$403K ﹤0.01% 1919
2025
Q3
$1.17M Sell
20,498
-14,033
-41% -$831K ﹤0.01% 1957
2025
Q2
$1.91M Buy
34,531
+13,593
+65% +$637K ﹤0.01% 2163
2025
Q1
$915K Buy
20,938
+603
+3% +$26.3K ﹤0.01% 2348
2024
Q4
$875K Buy
20,335
+3,639
+22% +$164K ﹤0.01% 2423
2024
Q3
$746K Sell
16,696
-2,269
-12% -$93.8K ﹤0.01% 2516
2024
Q2
$730K Buy
+18,965
New +$723K ﹤0.01% 2513

Other funds holding DBD

UBS AM's DBD Position: Q1 2026 in Review

UBS AM increased its Diebold Nixdorf (DBD) stake by 17% in Q1 2026, buying an estimated $339K and bringing the position to 31,561 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

UBS AM first reported a position in DBD in Q2 2024 and has held it in 8 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • UBS AM held 31,561 shares of Diebold Nixdorf worth $2.38M as of Q1 2026.
  • UBS AM bought 4,612 Diebold Nixdorf shares in Q1 2026, an estimated $339K.
  • Diebold Nixdorf made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1953 holding.
  • UBS AM first reported a position in Diebold Nixdorf in Q2 2024 and has held it in 8 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.